Chantix gains Approval For Quit Smoking In Canada As Champix
January 25, 2007
The quit smoking drug Chantix gains entry into the pharmaceutical market in Canada under the brand name Champix after the health authorities in the country have approved the medicine as an effective treatment for nicotine addiction in adults. Health authorities in Canada have approved Champix by measuring its performance and the medicine is likely to be available in Canadian pharmacies in late April.
Dr. Andrew Pipe, Medical Director of the " University of Ottawa Heart Institute Prevention and Rehabilitation Centre" comments that almost five million population of Canada is addicted to nicotine and as such the approval of Champix by the Canadian health authorities is good news for the country. He further asserts that the drug Champix which is used for inducing smoking cessation is capable of assisting the Canadians in getting rid of smoking addiction.
Dr. Bernard Prigent who is the vice president of medical affairs at Pfizer Incl. `s Canada branch pronounces that the sanction of Pfizer's product Champix by health Canada would yield promising results as Champix is an innovative medical tool to treat nicotine dependence in people.